BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -624.50% | -155.87% | 42.58% | 51.11% | -15.08% |
| Total Depreciation and Amortization | 730.65% | -12.68% | -52.98% | 639.29% | -118.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 443.28% | 146.09% | -295.35% | -20.76% | 146.20% |
| Change in Net Operating Assets | 1,048.62% | -111.79% | 343.46% | -205.53% | -217.25% |
| Cash from Operations | -14.62% | -135.23% | 68.17% | -0.54% | -12.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 469,900.00% | -- | -100.00% | 204.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 469,900.00% | -- | -100.00% | 105.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.30% | 857.93% | 68.23% | -188.21% | 646.90% |